V8 Peptides — Engineered Performance
Research Library
MOTS-c in Aged Mice: Published Findings on Physical Decline
MOTS-cGuide

MOTS-c in Aged Mice: Published Findings on Physical Decline

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer

What do published mouse studies report about MOTS-c and age-related decline? A 2021 study reported that MOTS-c enhanced physical performance in young (2 months), middle-aged (12 months) and old (22 months) mice, and that intermittent MOTS-c exposure (three times a week) begun late in life (23.5 months) increased physical capacity and healthspan. The 2015 discovery paper reported that exposure prevented age-dependent and high-fat-diet-induced insulin resistance. This article lays out what each study measured, how the experiments were built and where the evidence ends. It summarizes published animal work only. MOTS-c is supplied for laboratory research use only.

The question these studies ask

Aging research in rodents asks whether a manipulation changes how fast function declines: grip strength, running capacity, gait, glucose handling and body composition. For a peptide encoded in mitochondrial DNA, the natural hypothesis is that levels or activity of the peptide change with age or exercise and that adding it back could influence age-related functional decline. Two papers carry most of the weight, and a review of mitochondrial-derived peptides in aging pulls the wider evidence together.[1] The MOTS-c research overview covers the compound's profile; this page is limited to the aged-animal evidence.

The two anchor studies side by side

FeatureLee 2015[2]Reynolds 2021[3]
Main claimMOTS-c regulates insulin sensitivity and metabolic homeostasis; target organ appears to be skeletal muscleMOTS-c enhances physical performance across ages and is exercise-induced
Ages or statesAge-dependent and high-fat-diet-induced insulin resistanceYoung (2 mo), middle-age (12 mo), old (22 mo) mice
ExposureMOTS-c exposure in miceIncluding late-life (23.5 mo) intermittent exposure, 3x/week
Readouts named in abstractInsulin resistance; diet-induced obesityPhysical performance; nuclear gene regulation; skeletal muscle metabolism; myoblast adaptation to metabolic stress
Mechanistic statementFolate cycle and de novo purine biosynthesis inhibited, leading to AMPK activationRegulates nuclear genes related to metabolism and proteostasis
Human data in the same paperNone stated in the abstractExercise induces endogenous MOTS-c expression in skeletal muscle and in circulation

Both abstracts frame the finding as regulation by a mitochondrial-encoded factor. Reynolds and colleagues concluded that aging is regulated by genes encoded in both the mitochondrial and the nuclear genomes.[3]

The 2021 study in detail

The Reynolds study reported that MOTS-c could significantly enhance physical performance in mice at three ages, which is a design choice worth noting: testing at 2, 12 and 22 months separates an effect that appears only in old animals from one that is present throughout life. It also reported that MOTS-c regulates nuclear genes, including those related to metabolism and proteostasis, regulates skeletal muscle metabolism, and regulates myoblast adaptation to metabolic stress. Late-life initiation at 23.5 months with intermittent exposure three times a week was reported to increase physical capacity and healthspan in mice. In humans, exercise was reported to induce endogenous MOTS-c expression in skeletal muscle and in circulation.[3] A review of mitochondrial-derived peptides and exercise summarizes the evidence that acute high-intensity exercise in humans can increase MOTS-c and humanin concentrations in muscle and plasma, and speculates about the mechanisms.[4]

What the abstract does not tell a reader is the specific dose, the vehicle and the exact test battery, and those are the details to read in the full paper before attempting a comparison.

Ovariectomy and hormone-loss models

Aging is not the only model of metabolic decline in the literature. In ovariectomized mice, MOTS-c exposure was reported to prevent ovariectomy-induced obesity and insulin resistance, to increase brown fat activation, to reduce fat accumulation and inflammatory invasion in white adipose tissue, and to activate the AMPK pathway; an AMPK blocker attenuated the effect on adipocyte lipid metabolism.[5] Another ovariectomy study reported that MOTS-c at 5 mg/kg once a day for 12 weeks significantly alleviated bone loss by micro-CT and inhibited RANKL-induced osteoclast differentiation, with AMPK phosphorylation increased and the AMPK inhibitor compound C partially abrogating the effect on osteoclastogenesis.[6] These are separate disease models, but they share the AMPK mechanism, which is why they appear together in aging-adjacent reviews.

Model summary

ModelSpeciesReported outcomeSource
Age-dependent and high-fat-diet insulin resistanceMousePrevented by MOTS-c exposureLee 2015[2]
Physical performance at 2, 12 and 22 monthsMouseEnhancedReynolds 2021[3]
Late-life intermittent exposure from 23.5 monthsMousePhysical capacity and healthspan increasedReynolds 2021[3]
Ovariectomy-induced obesity and insulin resistanceMousePrevented; brown fat activity sustainedLu 2019[5]
Ovariectomy-induced bone lossMouseAlleviated by micro-CTMing 2016[6]
Senescent fibroblastsHuman cellsEndogenous peptide levels measured; more mitochondria, higher respirationKim 2018[7]

Each row is a separate experiment with its own controls and endpoints, so the table lists outcomes without implying that they add up to a single effect.

Cellular aging: senescence data

In primary human fibroblasts made senescent by replicative exhaustion, doxorubicin or hydrogen peroxide, researchers measured mitochondrial number, respiration, mtDNA methylation and the levels of humanin, MOTS-c, SHLP2 and SHLP6.[7] Senescent cells showed more mitochondria and higher respiration, with variable changes in mtDNA methylation. This is a cell model and it concerns endogenous peptide levels rather than the effect of adding a peptide; it is useful mainly as a reminder that "age-related" can mean different things at the cellular and organismal levels.

Limits of the evidence

  • Few anchor studies. Among the sources reviewed here, the aged-animal functional data rest mainly on one group's 2021 paper, with supporting model studies from others.
  • Different readouts. Physical performance, insulin sensitivity, bone loss and adipose function are separate endpoints; improvement in one does not imply the others.
  • Intermittent exposure was specific. The late-life design used a defined three-times-weekly schedule; other schedules were not shown by the abstract.
  • Association in humans. The human finding is that exercise induces endogenous MOTS-c, and a cross-sectional study of 225 subjects reported lower serum mitochondrial-derived peptide levels in diabetes subjects.[8] Both describe association.
  • Species. All exposure data cited are from mice.

Planning a replication-minded experiment

A group wanting to evaluate these findings in its own aging model should pre-specify age groups (young, middle, old), a defined functional battery (for example grip strength and treadmill capacity), randomization and blinding, and a vehicle arm exposed on the same schedule. Peptide material should be documented: lot, purity, COA and storage. The stock arithmetic is: concentration = mass (mg) ÷ 2,175 g/mol ÷ volume (mL) in mmol/mL; use the calculator. A lot-specific COA (lot ARC-MO10-007) is linked from the MOTS-c product page, and the identity and purity fields are explained in MOTS-c purity testing.

Research-use statement

This article reports published animal and cell studies. All material discussed here is supplied for laboratory research use only; not for human or animal consumption, and not a drug, food or cosmetic.

Related reading

Frequently asked questions

At what ages was MOTS-c tested in the 2021 mouse study?

Young (2 months), middle-aged (12 months) and old (22 months) mice, plus a late-life (23.5 months) intermittent exposure design.[3]

What exposure schedule was used in the late-life experiment?

Intermittent exposure three times a week, started at 23.5 months, per the abstract.[3]

What did the 2015 paper report about age and diet?

That MOTS-c exposure prevented age-dependent and high-fat-diet-induced insulin resistance and diet-induced obesity in mice.[2]

What happens to MOTS-c with exercise?

Exercise was reported to induce endogenous MOTS-c expression in human skeletal muscle and circulation.[3][4]

Which mechanism recurs across the studies?

AMPK activation, reported in the original paper and in two ovariectomy models.[2][5][6]

Were ovariectomized mice studied?

Yes. One study reported prevention of obesity and insulin resistance, and another reported reduced bone loss.[5][6]

What does a senescence study add?

It shows how endogenous MOTS-c and related peptides and mitochondrial function change in senescent human fibroblasts, but it is not a exposure study.[7]

Do these studies cover people?

No exposure data in people are cited. The human findings are about endogenous levels and association.[3][8]

What details should be read in the full paper?

Dose, vehicle, route, schedule and the exact test battery.

Is MOTS-c intended for people or animals?

No. It is supplied for laboratory research use only; not for human or animal consumption.

Related reading: MOTS-c and AMPK: Assays, Tool Compounds and Controls, MOTS-c, Exercise and Skeletal Muscle: Published Data, MOTS-c, Glucose Metabolism and Insulin Resistance Assays.

References

  1. Kim SJ, et al. Mitochondrial-derived peptides in aging and age-related diseases. GeroScience. 2021. doi:10.1007/s11357-020-00262-5 PMID: 32910336
  2. Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015. doi:10.1016/j.cmet.2015.02.009 PMID: 25738459
  3. Reynolds JC, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021. doi:10.1038/s41467-020-20790-0 PMID: 33473109
  4. Woodhead JST, et al. Mitochondrial-derived peptides and exercise. Biochim Biophys Acta Gen Subj. 2021. doi:10.1016/j.bbagen.2021.130011 PMID: 34520826
  5. Lu H, et al. MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction. J Mol Med. 2019. doi:10.1007/s00109-018-01738-w PMID: 30725119
  6. Ming GF, et al. Mitochondria related peptide MOTS-c suppresses ovariectomy-induced bone loss via AMPK activation. Biochem Biophys Res Commun. 2016. doi:10.1016/j.bbrc.2016.05.135 PMID: 27237975
  7. Kim SJ, et al. Mitochondrial peptides modulate mitochondrial function during cellular senescence. Aging. 2018. doi:10.18632/aging.101463 PMID: 29886458
  8. Ramanjaneya M, et al. Mitochondrial-derived peptides are down regulated in diabetes subjects. Front Endocrinol. 2019. doi:10.3389/fendo.2019.00331 PMID: 31214116

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.